These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21214583)

  • 21. Prenatal typing of fetal DNA in cases of potential alloimmune haemolytic disease of the newborn: clinical benefit outweighs disadvantage.
    Shields JA
    Br J Biomed Sci; 1999; 56(1):49-55. PubMed ID: 10492915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B; Zupańska B
    Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should we continue screening rhesus D positive women for the development of atypical antibodies in late pregnancy?
    Adeniji AA; Fuller I; Dale T; Lindow SW
    J Matern Fetal Neonatal Med; 2007 Jan; 20(1):59-61. PubMed ID: 17437201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolytic disease of the newborn due to rare alloantibodies.
    Zuliani G; Moroni GA; Buscaglia M; Morotti R; Pardi G
    Ric Clin Lab; 1983; 13(4):449-57. PubMed ID: 6419339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-D prevention. Review and outlook for 1976].
    Schneider J
    Fortschr Med; 1976 Nov; 94(31):1747-52. PubMed ID: 826466
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful management of pregnancy and hemolytic disease of the newborn due to anti-HrO in a woman of the D--phenotype.
    Deitenbeck R; Tutschek B; Crombach G; Stannigel H
    Transfusion; 1999 Oct; 39(10):1151-2. PubMed ID: 10532613
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 31. Measurement of the affinity of anti-D in the serum of immunized mothers and in immunoglobulin preparations with unlabeled antibodies.
    Debbia M; Brossard Y; Lambin P
    Transfusion; 2005 Jun; 45(6):975-83. PubMed ID: 15934997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The importance of pregnancy consultation in prophylaxis of hemolytic disease of the newborn].
    Kölbl H
    Wien Med Wochenschr; 1966 Nov; 116(46):981-3. PubMed ID: 4965843
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunological aspects of the prevention of hemolytic disease of the newborn].
    Antonian AK
    Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267
    [No Abstract]   [Full Text] [Related]  

  • 34. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
    Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
    BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemolytic disease of newborn caused by anti-E antibodies].
    Maszkiewicz W; Ornat K; Podwysocka M
    Pediatr Pol; 1977 Apr; 52(4):445-7. PubMed ID: 405650
    [No Abstract]   [Full Text] [Related]  

  • 36. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of serological incompatibility in the Rh c system].
    Kuś-Mikołajczyk Z
    Pediatr Pol; 1988 Apr; 63(4):262-3. PubMed ID: 3146054
    [No Abstract]   [Full Text] [Related]  

  • 38. Maternal CW alloimmunization.
    Bowman JM; Pollock J
    Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare case of hemolytic death of the newborn due to anti-hr0 and anti-e.
    Gong Y; Ai Y; Zhou R
    J Obstet Gynaecol Res; 2011 May; 37(5):465-7. PubMed ID: 21208345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Rh17 (anti-Hr0): a rare diagnostic and management problem.
    Salamat N; Bhatti FA; Hussain A; Ziaullah
    J Pak Med Assoc; 2004 Apr; 54(4):215-8. PubMed ID: 15242002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.